Johnson & Johnson Innovation (JJDC) is the strategic venture capital arm of Johnson & Johnson, focusing on investments in pharmaceuticals, medical devices, and consumer health that align with the parent company's scientific objectives and core business areas. Their strategy involves fostering breakthrough technologies to address unmet medical needs, taking a long-term investment view across all stages from early-stage startups to later rounds, and leveraging Johnson & Johnson's extensive capabilities to support portfolio companies.
71% of their portfolio is in Healthcare. Average disclosed round size is $64.5M (across 7 rounds with reported amounts).
Portfolio
7
Fund Size
$978M
Top Stage
Series B
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Citryll | Series B | $85M | Dec 2024 |
 MedCrypt, Inc. | Series B | $25M | Nov 2022 |
 Verana Health | Series E | $150M | Jan 2022 |
| IIterative Scopes | Series A | $30M | Aug 2021 |
 V-Wave Ltd. | Series C | $70M | Apr 2018 |
| SStix | Seed | $1.3M | — |
 Artera | Series C | $90M | — |
Top Co-Investors
Breyer Capital3 shared
BDMI1 shared
Intuitive Ventures1 shared
Section 321 shared
Eniac Ventures1 shared
Anzu Partners1 shared
Dolby Family Ventures1 shared
Obvious Ventures1 shared
Eli Lilly1 shared
Time BioVentures1 shared
Novo Holdings1 shared
GV (Google Ventures)1 shared
Casdin Capital1 shared
Merck Global Health Innovation Fund1 shared
THVC1 shared
Forbion1 shared
Novartis Venture Fund1 shared
Pureos Bioventures1 shared
BioGeneration Ventures1 shared
Seventure Partners1 shared
Last updated: 16 April 2026